EQS — News: Kedrion: at ESID 2026, experts call for earlier diagnosis and greater awareness as Secondary Immunodeficiencies continue to rise

EQS-News: Kedrion / Key word(s): Miscellaneous Kedrion: at ESID 2026, experts call for earlier diagnosis and greater awareness as Secondary Immunodeficiencies continue to rise 14.10.2026 / 10:05 CET/CEST The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════ MAASTRICHT, Netherlands, Oct. 14, 2026 // -- Secondary Immunodeficiencies (SIDs) represent a significant and frequently under-recognized healthcare challenge. Their clinical relevance has increased with the expanding use of immunosuppressive and biologic therapies, advances in the treatment of hematological malignancies, and the growing number of patients exposed to conditions associated with acquired immune dysfunction. 1 Kedrion To address this situation, physicians, patient advocates, researchers and industry representatives gathering at ESID 2026 are calling for greater attention to Secondary Immunodeficiencies and the challenges faced by those living with these conditions. Despite advances in understanding these